<DOC>
	<DOCNO>NCT02972372</DOCNO>
	<brief_summary>The aim study compare outcome Chinese patient locally advance resectable esophageal squamous cell cancer receive either surgery definitive chemoradiation ( CRT ) randomize , open-label , multicenter trial .</brief_summary>
	<brief_title>Chemoradiation Versus Esophagectomy Locally Advanced Esophageal Cancer</brief_title>
	<detailed_description>Background : More half global esophageal cancer case come China , report definitive chemoradiation ( CRT ) compare esophagectomy Chinese patient locally advance resectable esophageal squamous cell cancer ( ESCC ) limit . Aim : compare outcomes Chinese patient locally advance resectable esophageal squamous cell cancer receive either surgery definitive chemoradiation ( CRT ) . Methods : 176 ESCC patient T1bN+M0 , T2-4aN0-2M0 randomize CRT group Surgery group.In CRT group , patient give intensity modulation radiation therapy ( IMRT ) 50Gy/25 fraction , current chemotherapy 5-fluorouracil ( 5-FU ) basic regimen . In surgery group , patient receive standard esophagectomy . 5 year follow-up group patient . Primary endpoint : 2 year 5 year Disease free survival , Overall survival Second endpoint : treatment-related adverse event ; quality life</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<criteria>Chinese esophageal squamous cell cancer mid low esophageal cancer tumor resectable disease clinical stage : cT1bN+Mo , cT24aN02M0 distant metastasis solid visceral organ local invasion trachea , descend aorta , recurrent laryngeal nerve . serious premorbid condition poor physical status compromise thoracotomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>esophageal cancer</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>esophagectomy</keyword>
</DOC>